ADAMA (000553) Q2 2024 earnings summary

Executive summary

• H1 2024 sales declined 16% year-over-year to $2.1 billion, driven by lower prices and volumes amid high competition and just-in-time purchasing trends.

• Adjusted EBITDA for Q2 2024 rose 7% year-over-year, with improved gross and EBITDA margins in both Q2 and H1 2024 due to strict inventory and OPEX management.

• Net loss for H1 2024 widened, with reported net loss at $154 million and adjusted net loss at $71 million, reflecting margin compression and non-operational charges.

• Positive operating cash flow of $243 million and free cash flow of $51 million were achieved through strict working capital and inventory management.

• The transformation plan and Fight Forward initiative are underway, showing initial benefits in profitability and cash flow, with further acceleration expected.

Financial highlights

• H1 2024 sales fell to $2.1 billion from $2.5 billion in H1 2023; Q2 sales dropped 16% year-over-year to $1.04 billion.

• H1 2024 gross profit was $557 million (down 10%), with gross margin up to 26.5%; Q2 gross margin improved to 25.8%.

• H1 2024 adjusted EBITDA was $252 million (down 9%), EBITDA margin at 12.0%; Q2 adjusted EBITDA reached $120 million (up 7%), margin at 11.5%.

• Net loss for H1 2024 was $154 million (reported) and $71 million (adjusted); operating cash flow improved by $243 million year-over-year.

• Inventory reduced by $609 million year-over-year; inventory days at 181, the lowest in recent quarters.

Outlook and guidance

• No full-year guidance provided; management commits to ongoing transformation, business quality improvement, and cash flow focus.

• Market recovery remains uncertain, with ongoing pricing pressure, high competition, and just-in-time purchasing patterns expected to persist.

• Focus continues on higher-margin, differentiated products and strict inventory and OPEX management.

• CapEx will remain focused on must-have and short ROI projects, with further reductions expected.